| Silencing of NRF2 reduces the expression of ALDH1A1 and ALDH3A1 and sensitizes to 5-FU in pancreatic cancer cells HQ Duong, KS You, S Oh, SJ Kwak, YS Seong Antioxidants 6 (3), 52, 2017 | 64 | 2017 |
| Ribosomal protein S6: a potential therapeutic target against cancer? YW Yi, KS You, JS Park, SG Lee, YS Seong International journal of molecular sciences 23 (1), 48, 2021 | 57 | 2021 |
| Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6 YW Yi, K You, EJ Bae, SJ Kwak, YS Seong, I Bae International Journal of Oncology 47 (1), 122-132, 2015 | 43 | 2015 |
| Potentiating therapeutic effects of epidermal growth factor receptor inhibition in triple-negative breast cancer KS You, YW Yi, J Cho, JS Park, YS Seong Pharmaceuticals 14 (6), 589, 2021 | 34 | 2021 |
| Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells KS You, YW Yi, SJ Kwak, YS Seong International journal of oncology 52 (3), 828-840, 2018 | 33 | 2018 |
| Dual inhibition of AKT and MEK pathways potentiates the anti-cancer effect of gefitinib in triple-negative breast cancer cells KS You, YW Yi, J Cho, YS Seong Cancers 13 (6), 1205, 2021 | 29 | 2021 |
| Inhibition of IκB kinase is a potential therapeutic strategy to circumvent resistance to epidermal growth factor receptor inhibition in triple-negative breast cancer cells YW Yi, KS You, S Han, IJ Ha, JS Park, SG Lee, YS Seong Cancers 14 (21), 5215, 2022 | 5 | 2022 |
| Anaplastic lymphoma kinase inhibitor NVP‑TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells HQ Duong, VT Than, HT Nguyen, PT Nguyen, HTH Thi, TNH Bui, ... Oncology Reports 45 (4), 1-11, 2021 | 4 | 2021 |
| Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells. Cancers 2021, 13, 1205 KS You, YW Yi, J Cho, YS Seong s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 3 | 2021 |
| Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells … YW Yi, KS You, S Han, IJ Ha, JS Park, SG Lee, YS Seong s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
